A null mutation of the neuronal sodium channel NaV1.6 disrupts action potential propagation and excitation‐contraction coupling in the mouse heart

Evidence supports the expression of brain‐type sodium channels in the heart. Their functional role, however, remains controversial. We used global NaV1.6‐null mice to test the hypothesis that NaV1.6 contributes to the maintenance of propagation in the myocardium and to excitation‐contraction (EC) coupling. We demonstrated expression of transcripts encoding full‐length NaV1.6 in isolated ventricular myocytes and confirmed the striated pattern of NaV1.6 fluorescence in myocytes. On the ECG, the PR and QRS intervals were prolonged in the null mice, and the Ca2+ transients were longer in the null cells. Under patch clamping, at holding potential (HP) = –120 mV, the peak INa was similar in both phenotypes. However, at HP = –70 mV, the peak INa was smaller in the nulls. In optical mapping, at 4 mM [K+]o, 17 null hearts showed slight (7%) reduction of ventricular conduction velocity (CV) compared to 16 wild‐type hearts. At 12 mM [K+]o, CV was 25% slower in a subset of 9 null vs. 9 wild‐type hearts. These results highlight the importance of neuronal sodium channels in the heart, whereby NaV1.6 participates in EC coupling, and represents an intrinsic depolarizing reserve that contributes to excitation.—Noujaim, S. F., Kaur, K., Milstein, M., Jones, J. M., Furspan, P., Jiang, D., Auerbach, D. S., Herron, T., Meisler, M. H., Jalife, J. A null mutation of the neuronal sodium channel NaV1.6 disrupts action potential propagation and excitation‐contraction coupling in the mouse heart. FASEB J. 26, 63–72 (2012). www.fasebj.orgPeer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/154524/1/fsb2fj10179770.pd

How Similar Are the Mice to Men? Between-Species Comparison of Left Ventricular Mechanics Using Strain Imaging

BACKGROUND: While mammalian heart size maintains constant proportion to whole body size, scaling of left ventricular (LV) function parameters shows a more complex scaling pattern. We used 2-D speckle tracking strain imaging to determine whether LV myocardial strains and strain rates scale to heart size. METHODS: We studied 18 mice, 15 rats, 6 rabbits, 12 dogs and 20 human volunteers by 2-D echocardiography. Relationship between longitudinal or circumferential strains/strain rates (S(Long)/SR(Long), S(Circ)/SR(Circ)), and LV end-diastolic volume (EDV) or mass were assessed by the allometric (power-law) equation Y = kM(β). RESULTS: Mean LV mass in individual species varied from 0.038 to 134 g, LV EDV varied from 0.015 to 102 ml, while RR interval varied from 81 to 1090 ms. While S(Long) increased with increasing LV EDV or mass (β values 0.047±0.006 and 0.051±0.005, p<0.0001 vs. 0 for both) S(Circ) was unchanged (p = NS for both LV EDV or mass). Systolic and diastolic SR(Long) and SR(Circ) showed inverse correlations to LV EDV or mass (p<0.0001 vs. 0 for all comparisons). The ratio between S(Long) and S(Circ) increased with increasing values of LV EDV or mass (β values 0.039±0.010 and 0.040±0.011, p>0.0003 for both). CONCLUSIONS: While S(Circ) is unchanged, S(Long) increases with increasing heart size, indicating that large mammals rely more on long axis contribution to systolic function. SR(Long) and SR(Circ), both diastolic and systolic, show an expected decrease with increasing heart size

Estrogen Induced Metastatic Modulators MMP-2 and MMP-9 Are Targets of 3,3′-Diindolylmethane in Thyroid Cancer

Thyroid cancer is the most common endocrine related cancer with increasing incidences during the past five years. Current treatments for thyroid cancer, such as surgery or radioactive iodine therapy, often require patients to be on lifelong thyroid hormone replacement therapy and given the significant recurrence rates of thyroid cancer, new preventive modalities are needed. The present study investigates the property of a natural dietary compound found in cruciferous vegetables, 3,3'-diindolylmethane (DIM), to target the metastatic phenotype of thyroid cancer cells through a functional estrogen receptor.Thyroid cancer cell lines were treated with estrogen and/or DIM and subjected to in vitro adhesion, migration and invasion assays to investigate the anti-metastatic and anti-estrogenic effects of DIM. We observed that DIM inhibits estrogen mediated increase in thyroid cell migration, adhesion and invasion, which is also supported by ER-α downregulation (siRNA) studies. Western blot and zymography analyses provided direct evidence for this DIM mediated inhibition of E(2) enhanced metastasis associated events by virtue of targeting essential proteolytic enzymes, namely MMP-2 and MMP-9.Our data reports for the first time that DIM displays anti-estrogenic like activity by inhibiting estradiol enhanced thyroid cancer cell proliferation and in vitro metastasis associated events, namely adhesion, migration and invasion. Most significantly, MMP-2 and MMP-9, which are known to promote and enhance metastasis, were determined to be targets of DIM. This anti-estrogen like property of DIM may lead to the development of a novel preventive and/or therapeutic dietary supplement for thyroid cancer patients by targeting progression of the disease

Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria

Gain-of-function mutations in KCNJ2-encoded Kir2.1 channels underlie variant 3 (SQT3) of the short QT syndrome, which is associated with atrial fibrillation (AF). Using biophysically-detailed human atria computer models, this study investigated the mechanistic link between SQT3 mutations and atrial arrhythmogenesis, and potential ion channel targets for treatment of SQT3. A contemporary model of the human atrial action potential (AP) was modified to recapitulate functional changes in IK1 due to heterozygous and homozygous forms of the D172N and E299V Kir2.1 mutations. Wild-type (WT) and mutant formulations were incorporated into multi-scale homogeneous and heterogeneous tissue models. Effects of mutations on AP duration (APD), conduction velocity (CV), effective refractory period (ERP), tissue excitation threshold and their rate-dependence, as well as the wavelength of re-entry (WL) were quantified. The D172N and E299V Kir2.1 mutations produced distinct effects on IK1 and APD shortening. Both mutations decreased WL for re-entry through a reduction in ERP and CV. Stability of re-entrant excitation waves in 2D and 3D tissue models was mediated by changes to tissue excitability and dispersion of APD in mutation conditions. Combined block of IK1 and IKr was effective in terminating re-entry associated with heterozygous D172N conditions, whereas IKr block alone may be a safer alternative for the E299V mutation. Combined inhibition of IKr and IKur produced a synergistic anti-arrhythmic effect in both forms of SQT3. In conclusion, this study provides mechanistic insights into atrial proarrhythmia with SQT3 Kir2.1 mutations and highlights possible pharmacological strategies for management of SQT3-linked AF

Ovarian cancer immunotherapy: opportunities, progresses and challenges

Due to the low survival rates from invasive ovarian cancer, new effective treatment modalities are urgently needed. Compelling evidence indicates that the immune response against ovarian cancer may play an important role in controlling this disease. We herein summarize multiple immune-based strategies that have been proposed and tested for potential therapeutic benefit against advanced stage ovarian cancer. We will examine the evidence for the premise that an effective therapeutic vaccine against ovarian cancer is useful not only for inducing remission of the disease but also for preventing disease relapse. We will also highlight the questions and challenges in the development of ovarian cancer vaccines, and critically discuss the limitations of some of the existing immunotherapeutic strategies. Finally, we will summarize our own experience on the use of patient-specific tumor-derived heat shock protein-peptide complex for the treatment of advanced ovarian cancer

Nerves projecting from the intrinsic cardiac ganglia of the pulmonary veins modulate sinoatrial node pacemaker function

Rationale: Autonomic nerves from sinoatrial node (SAN) ganglia are known to regulate SAN function. However, it is unclear whether remote pulmonary vein ganglia (PVG) also modulate SAN pacemaker rhythm. Objective: To investigate whether in the mouse heart PVG modulate SAN function. Methods and Results: In hearts from 45 C57BL and 7 Connexin40+/GFP mice, we used tyrosine-hydroxylase (TH) and choline-acetyltransferase (ChAT) immunofluorescence labeling to characterize adrenergic and cholinergic elements, repectively, within the PVG and SAN. PVG project postganglionic nerves to the SAN. TH and ChAT stained nerves, enter the SAN as an extensive, dense mesh-like neural network. Neurons in PVG are biphenotypic, containing ChAT and TH positive neurons. In Langendorff-perfused hearts, we compared effects of electrical stimulation of PVG, posterior (PRCVG) and anterior right vena cava ganglia (ARCVG) using 200-2000 ms trains of pulses (300&#956;s, 0.2-0.6mA, 200Hz). Sympathetic and/or parasympathetic blockade was achieved using 0.5&#956;M propranolol and 1&#956;M atropine, respectively. Epicardial optical mapping of SAN activation was performed before, during and after ganglion stimulation. PVG stimulation increased the P-P interval by 36±9%; PRCVG stimulation increased the P-P interval by 42±11%. ARCVG stimulation produced no change. Propranolol perfusion increased the PVG stimulation effect to 43±13%. Atropine caused a 5±6% decrease. In optical mapping experiments of whole hearts and isolated atrial preparations, PVG stimulation shifted the origin of SAN discharges to varying locations. Conclusions: PVG contain cholinergic, adrenergic and biphenotipic neurons whose axons project across the right atrium to richly innervate the SAN region and contribute significantly to regulation of SAN function.Zarzoso Muñoz, M.; Rysevaite, K.; Milstein, ML.; Calvo Saiz, CJ.; Kean, AC.; Atienza Fernández, F.; Pauza, DH.... (2013). Nerves projecting from the intrinsic cardiac ganglia of the pulmonary veins modulate sinoatrial node pacemaker function. Cardiovascular Research. 566-575. doi:10.1093/cvr/cvt081S566575Johnson, T. A., Gray, A. L., Lauenstein, J.-M., Newton, S. S., & Massari, V. J. (2004). Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles. Journal of Applied Physiology, 96(6), 2265-2272. doi:10.1152/japplphysiol.00620.2003Rysevaite, K., Saburkina, I., Pauziene, N., Noujaim, S. F., Jalife, J., & Pauza, D. H. (2011). Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart. Heart Rhythm, 8(3), 448-454. doi:10.1016/j.hrthm.2010.11.019Yuan, B.-X., Ardell, J. L., Hopkins, D. A., & Armour, J. A. (1993). Differential cardiac responses induced by nicotine sensitive canine atrial and ventricular neurones. Cardiovascular Research, 27(5), 760-769. doi:10.1093/cvr/27.5.760Rysevaite, K., Saburkina, I., Pauziene, N., Vaitkevicius, R., Noujaim, S. F., Jalife, J., & Pauza, D. H. (2011). Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations. Heart Rhythm, 8(5), 731-738. doi:10.1016/j.hrthm.2011.01.013Pauza, D. H., Pauziene, N., Pakeltyte, G., & Stropus, R. (2002). Comparative quantitative study of the intrinsic cardiac ganglia and neurons in the rat, guinea pig, dog and human as revealed by histochemical staining for acetylcholinesterase. Annals of Anatomy - Anatomischer Anzeiger, 184(2), 125-136. doi:10.1016/s0940-9602(02)80005-xPauza, D. H., Skripka, V., & Pauziene, N. (2002). Morphology of the Intrinsic Cardiac Nervous System in the Dog: A Whole-Mount Study Employing Histochemical Staining with Acetylcholinesterase. Cells Tissues Organs, 172(4), 297-320. doi:10.1159/000067198Arora, R. C., Waldmann, M., Hopkins, D. A., & Armour, J. A. (2003). Porcine intrinsic cardiac ganglia. The Anatomical Record, 271A(1), 249-258. doi:10.1002/ar.a.10030Gatti, P. J., Johnson, T. A., & John Massari, V. (1996). Can neurons in the nucleus ambiguus selectively regulate cardiac rate and atrio-ventricular conduction? Journal of the Autonomic Nervous System, 57(1-2), 123-127. doi:10.1016/0165-1838(95)00104-2Zhuang, S., Zhang, Y., Mowrey, K. A., Li, J., Tabata, T., Wallick, D. W., … Mazgalev, T. N. (2002). Ventricular Rate Control by Selective Vagal Stimulation Is Superior to Rhythm Regularization by Atrioventricular Nodal Ablation and Pacing During Atrial Fibrillation. Circulation, 106(14), 1853-1858. doi:10.1161/01.cir.0000031802.58532.04CHEN, J., WASMUND, S. L., & HAMDAN, M. H. (2006). Back to the Future: The Role of the Autonomic Nervous System in Atrial Fibrillation. Pacing and Clinical Electrophysiology, 29(4), 413-421. doi:10.1111/j.1540-8159.2006.00362.xArmour, J. A. (2008). Potential clinical relevance of the ‘little brain’ on the mammalian heart. Experimental Physiology, 93(2), 165-176. doi:10.1113/expphysiol.2007.041178LAZZARA, R., SCHERLAG, B. J., ROBINSON, M. J., & SAMET, P. (1973). Selective In Situ Parasympathetic Control of the Canine Sinoatrial and Atrioventricular Nodes. Circulation Research, 32(3), 393-401. doi:10.1161/01.res.32.3.393Gray, A. L., Johnson, T. A., Ardell, J. L., & Massari, V. J. (2004). Parasympathetic control of the heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate. Journal of Applied Physiology, 96(6), 2273-2278. doi:10.1152/japplphysiol.00616.2003Pappone, C., Santinelli, V., Manguso, F., Vicedomini, G., Gugliotta, F., Augello, G., … Alfieri, O. (2004). Pulmonary Vein Denervation Enhances Long-Term Benefit After Circumferential Ablation for Paroxysmal Atrial Fibrillation. Circulation, 109(3), 327-334. doi:10.1161/01.cir.0000112641.16340.c7MIQUEROL, L., MEYSEN, S., MANGONI, M., BOIS, P., VANRIJEN, H., ABRAN, P., … GROS, D. (2004). Architectural and functional asymmetry of the His–Purkinje system of the murine heart. Cardiovascular Research, 63(1), 77-86. doi:10.1016/j.cardiores.2004.03.007Jalife, J., Slenter, V. A., Salata, J. J., & Michaels, D. C. (1983). Dynamic vagal control of pacemaker activity in the mammalian sinoatrial node. Circulation Research, 52(6), 642-656. doi:10.1161/01.res.52.6.642Fedorov, V. V., Hucker, W. J., Dobrzynski, H., Rosenshtraukh, L. V., & Efimov, I. R. (2006). Postganglionic nerve stimulation induces temporal inhibition of excitability in rabbit sinoatrial node. American Journal of Physiology-Heart and Circulatory Physiology, 291(2), H612-H623. doi:10.1152/ajpheart.00022.2006Saburkina, I., & Pauza, D. H. (2006). Location and variability of epicardiac ganglia in human fetuses. Anatomy and Embryology, 211(6), 585-594. doi:10.1007/s00429-006-0110-4Slavíková, J., Kuncová, J., Reischig, J., & Dvořáková, M. (2003). Neurochemical Research, 28(3/4), 593-598. doi:10.1023/a:1022837810357Tan, A. Y., Li, H., Wachsmann-Hogiu, S., Chen, L. S., Chen, P.-S., & Fishbein, M. C. (2006). Autonomic Innervation and Segmental Muscular Disconnections at the Human Pulmonary Vein-Atrial Junction. Journal of the American College of Cardiology, 48(1), 132-143. doi:10.1016/j.jacc.2006.02.054Vaitkevicius, R., Saburkina, I., Rysevaite, K., Vaitkeviciene, I., Pauziene, N., Zaliunas, R., … Pauza, D. H. (2009). Nerve Supply of the Human Pulmonary Veins: An Anatomical Study. Heart Rhythm, 6(2), 221-228. doi:10.1016/j.hrthm.2008.10.027Mabe, A. M., & Hoover, D. B. (2009). Structural and functional cardiac cholinergic deficits in adult neurturin knockout mice. Cardiovascular Research, 82(1), 93-99. doi:10.1093/cvr/cvp029Beau, S. L., Hand, D. E., Schuessler, R. B., Bromberg, B. I., Kwon, B., Boineau, J. P., & Saffitz, J. E. (1995). Relative Densities of Muscarinic Cholinergic and β-Adrenergic Receptors in the Canine Sinoatrial Node and Their Relation to Sites of Pacemaker Activity. Circulation Research, 77(5), 957-963. doi:10.1161/01.res.77.5.957Mangoni, M. E., & Nargeot, J. (2008). Genesis and Regulation of the Heart Automaticity. Physiological Reviews, 88(3), 919-982. doi:10.1152/physrev.00018.2007Brack, K. E., Coote, J. H., & Ng, G. A. (2003). Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart. Experimental Physiology, 89(1), 128-139. doi:10.1113/expphysiol.2003.002654Levy, M. N., & Zieske, H. (1969). Autonomic control of cardiac pacemaker activity and atrioventricular transmission. Journal of Applied Physiology, 27(4), 465-470. doi:10.1152/jappl.1969.27.4.465Hartzell, H. C. (1988). Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. Progress in Biophysics and Molecular Biology, 52(3), 165-247. doi:10.1016/0079-6107(88)90014-4LEVY, M. N., YANG, T., & WALLICK, D. W. (1993). Assessment of Beat-by-Beat Control of Heart Rate by the Autonomic Nervous System: Molecular Biology Techniques Are Necessary, But Not Sufficient. Journal of Cardiovascular Electrophysiology, 4(2), 183-193. doi:10.1111/j.1540-8167.1993.tb01222.xLevy, M. N. (1971). Brief Reviews. Circulation Research, 29(5), 437-445. doi:10.1161/01.res.29.5.437Ng, G. A., Brack, K. E., & Coote, J. H. (2001). Effects of Direct Sympathetic and Vagus Nerve Stimulation on the Physiology of the Whole Heart - A Novel Model of Isolated Langendorff Perfused Rabbit Heart with Intact Dual Autonomic Innervation. Experimental Physiology, 86(3), 319-329. doi:10.1113/eph8602146Goldberg, J. (1975). Intra-SA-nodal pacemaker shifts induced by autonomic nerve stimulation in the dog. American Journal of Physiology-Legacy Content, 229(4), 1116-1123. doi:10.1152/ajplegacy.1975.229.4.1116Shibata, N., Inada, S., Mitsui, K., Honjo, H., Yamamoto, M., Niwa, R., … Kodama, I. (2001). Pacemaker Shift in the Rabbit Sinoatrial Node in Response to Vagal Nerve Stimulation. Experimental Physiology, 86(2), 177-184. doi:10.1113/eph8602100Glukhov, A. V., Fedorov, V. V., Anderson, M. E., Mohler, P. J., & Efimov, I. R. (2010). Functional anatomy of the murine sinus node: high-resolution optical mapping of ankyrin-B heterozygous mice. American Journal of Physiology-Heart and Circulatory Physiology, 299(2), H482-H491. doi:10.1152/ajpheart.00756.2009Michaels, D. C., Matyas, E. P., & Jalife, J. (1987). Mechanisms of sinoatrial pacemaker synchronization: a new hypothesis. Circulation Research, 61(5), 704-714. doi:10.1161/01.res.61.5.704Boyett, M. (2000). The sinoatrial node, a heterogeneous pacemaker structure. Cardiovascular Research, 47(4), 658-687. doi:10.1016/s0008-6363(00)00135-8Lemery, R., Birnie, D., Tang, A. S. L., Green, M., & Gollob, M. (2006). Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm, 3(4), 387-396. doi:10.1016/j.hrthm.2006.01.009Pokushalov, E., Romanov, A., Shugayev, P., Artyomenko, S., Shirokova, N., Turov, A., & Katritsis, D. G. (2009). Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm, 6(9), 1257-1264. doi:10.1016/j.hrthm.2009.05.018Scherlag, B. J., Nakagawa, H., Jackman, W. M., Yamanashi, W. S., Patterson, E., Po, S., & Lazzara, R. (2005). Electrical Stimulation to Identify Neural Elements on the Heart: Their Role in Atrial Fibrillation. Journal of Interventional Cardiac Electrophysiology, 13(S1), 37-42. doi:10.1007/s10840-005-2492-2Puodziukynas, A., Kazakevicius, T., Vaitkevicius, R., Rysevaite, K., Jokubauskas, M., Saburkina, I., … Pauza, D. H. (2012). Radiofrequency catheter ablation of pulmonary vein roots results in axonal degeneration of distal epicardial nerves. Autonomic Neuroscience, 167(1-2), 61-65. doi:10.1016/j.autneu.2012.01.001Bauer, A., Deisenhofer, I., Schneider, R., Zrenner, B., Barthel, P., Karch, M., … Schmidt, G. (2006). Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function. Heart Rhythm, 3(12), 1428-1435. doi:10.1016/j.hrthm.2006.08.025Armour, J. A. (2010). Functional anatomy of intrathoracic neurons innervating the atria and ventricles. Heart Rhythm, 7(7), 994-996. doi:10.1016/j.hrthm.2010.02.01

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA) is a widely abused illicit drug. In animals, high-dose administration of MDMA produces deficits in serotonin (5-HT) neurons (e.g., depletion of forebrain 5-HT) that have been interpreted as neurotoxicity. Whether such 5-HT deficits reflect neuronal damage is a matter of ongoing debate. OBJECTIVE: The present paper reviews four specific issues related to the hypothesis of MDMA neurotoxicity in rats: (1) the effects of MDMA on monoamine neurons, (2) the use of “interspecies scaling” to adjust MDMA doses across species, (3) the effects of MDMA on established markers of neuronal damage, and (4) functional impairments associated with MDMA-induced 5-HT depletions. RESULTS: MDMA is a substrate for monoamine transporters, and stimulated release of 5-HT, NE, and DA mediates effects of the drug. MDMA produces neurochemical, endocrine, and behavioral actions in rats and humans at equivalent doses (e.g., 1–2 mg/kg), suggesting that there is no reason to adjust doses between these species. Typical doses of MDMA causing long-term 5-HT depletions in rats (e.g., 10–20 mg/kg) do not reliably increase markers of neurotoxic damage such as cell death, silver staining, or reactive gliosis. MDMA-induced 5-HT depletions are accompanied by a number of functional consequences including reductions in evoked 5-HT release and changes in hormone secretion. Perhaps more importantly, administration of MDMA to rats induces persistent anxiety-like behaviors in the absence of measurable 5-HT deficits. CONCLUSIONS: MDMA-induced 5-HT depletions are not necessarily synonymous with neurotoxic damage. However, doses of MDMA which do not cause long-term 5-HT depletions can have protracted effects on behavior, suggesting even moderate doses of the drug may pose risks